Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. [electronic resource]
Producer: 20111220Description: 169-76 p. digitalISSN:- 1521-7035
- Alemtuzumab
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm
- Bone Marrow Transplantation
- Cell Survival
- Forkhead Transcription Factors -- deficiency
- Genetic Diseases, X-Linked -- genetics
- Graft Enhancement, Immunologic
- Graft Survival
- Humans
- Immunologic Deficiency Syndromes -- genetics
- Infant
- Interleukin-2 Receptor alpha Subunit -- analysis
- Lymphocyte Depletion
- Male
- Melphalan
- Point Mutation
- T-Lymphocyte Subsets -- cytology
- T-Lymphocytes, Regulatory -- cytology
- Thiotepa
- Thymus Gland -- immunology
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.